DE602006002612D1 - Herstellung von (s)-4-fluormethyl-dihydro-furan-2-on - Google Patents

Herstellung von (s)-4-fluormethyl-dihydro-furan-2-on

Info

Publication number
DE602006002612D1
DE602006002612D1 DE602006002612T DE602006002612T DE602006002612D1 DE 602006002612 D1 DE602006002612 D1 DE 602006002612D1 DE 602006002612 T DE602006002612 T DE 602006002612T DE 602006002612 T DE602006002612 T DE 602006002612T DE 602006002612 D1 DE602006002612 D1 DE 602006002612D1
Authority
DE
Germany
Prior art keywords
fluoromethyl
furan
dihydro
preparation
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006002612T
Other languages
English (en)
Inventor
Stefan Abrecht
Jean-Michel Adam
Alec Fettes
Joseph Foricher
Bruno Lohri
Patrizio Mattei
Gerard Moine
Rudolf Schmid
Ulrich Zutter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE602006002612D1 publication Critical patent/DE602006002612D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/58—One oxygen atom, e.g. butenolide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE602006002612T 2005-05-24 2006-05-15 Herstellung von (s)-4-fluormethyl-dihydro-furan-2-on Active DE602006002612D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05104408 2005-05-24
PCT/EP2006/062291 WO2006125728A1 (en) 2005-05-24 2006-05-15 Preparation of (s)-4-fluoromethyl-dihydro-furan-2-one

Publications (1)

Publication Number Publication Date
DE602006002612D1 true DE602006002612D1 (de) 2008-10-16

Family

ID=36764569

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006002612T Active DE602006002612D1 (de) 2005-05-24 2006-05-15 Herstellung von (s)-4-fluormethyl-dihydro-furan-2-on

Country Status (15)

Country Link
US (1) US7619101B2 (de)
EP (1) EP1893595B1 (de)
JP (1) JP4219975B2 (de)
KR (1) KR100927910B1 (de)
CN (1) CN101180282B (de)
AT (1) ATE407126T1 (de)
AU (1) AU2006251253B2 (de)
BR (1) BRPI0611196A2 (de)
CA (1) CA2607927C (de)
DE (1) DE602006002612D1 (de)
ES (1) ES2313672T3 (de)
IL (1) IL187001A (de)
MX (1) MX2007014494A (de)
TW (1) TWI310767B (de)
WO (1) WO2006125728A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008031750A2 (en) * 2006-09-15 2008-03-20 F. Hoffmann-La Roche Ag Process for the preparation of pyrido[2,1-a]isoquinoline derivatives by catalytic asymmetric hydrogenation of an enamine
US7956201B2 (en) * 2006-11-06 2011-06-07 Hoffman-La Roche Inc. Process for the preparation of (S)-4-fluoromethyl-dihydro-furan-2-one
US20090105480A1 (en) * 2007-08-30 2009-04-23 Ulrike Bromberger Process for the preparation of a dpp-iv inhibitor
US20090163718A1 (en) * 2007-12-19 2009-06-25 Stefan Abrecht PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES
KR102493603B1 (ko) * 2013-11-15 2023-01-31 에프. 호프만-라 로슈 아게 피리미딘일사이클로펜테인 화합물의 제조 방법
CN108558797B (zh) * 2018-05-28 2020-04-17 华南师范大学 双醚化呋喃酮含氟衍生物及其制备方法与在制备抗肿瘤药物中的应用
CN113620913A (zh) * 2021-07-26 2021-11-09 安徽华业香料股份有限公司 一种γ-壬烯内酯的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3204667B2 (ja) * 1991-03-15 2001-09-04 エフ・ホフマン―ラ ロシユ アーゲー キラルなホスフイン
US6545165B1 (en) 2000-02-04 2003-04-08 Roche Colorado Corporation Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
DE10157533A1 (de) * 2001-11-23 2003-06-05 Bayer Cropscience Ag Verfahren zur Herstellung von chiral, nicht-racemischen 5-substituierten gamma-Butyrolactonen
ITMI20020415A1 (it) * 2002-03-01 2003-09-01 Chemi Spa Catalizzatori metallici per reazione chemo- regio- stereo-selettive erelativi precursori
DE602004030244D1 (de) * 2003-06-20 2011-01-05 Hoffmann La Roche Itoren

Also Published As

Publication number Publication date
BRPI0611196A2 (pt) 2010-08-24
TWI310767B (en) 2009-06-11
AU2006251253B2 (en) 2012-03-15
WO2006125728A1 (en) 2006-11-30
TW200722425A (en) 2007-06-16
US20060270853A1 (en) 2006-11-30
KR20080012885A (ko) 2008-02-12
CA2607927C (en) 2014-12-30
ATE407126T1 (de) 2008-09-15
EP1893595A1 (de) 2008-03-05
EP1893595B1 (de) 2008-09-03
JP4219975B2 (ja) 2009-02-04
CN101180282B (zh) 2011-09-21
JP2008545673A (ja) 2008-12-18
IL187001A0 (en) 2008-02-09
AU2006251253A1 (en) 2006-11-30
CA2607927A1 (en) 2006-11-30
ES2313672T3 (es) 2009-03-01
US7619101B2 (en) 2009-11-17
MX2007014494A (es) 2008-02-11
CN101180282A (zh) 2008-05-14
KR100927910B1 (ko) 2009-11-19
IL187001A (en) 2012-08-30

Similar Documents

Publication Publication Date Title
NL300933I2 (nl) Letermovir
TW200630374A (en) Thiazolyldihydroindazoles
UY29927A1 (es) Derivados sustituidos de la 5-fenil-2-tioxo-imidazolin-4-ona y de la 5-fenil-2-amino-imidazolidin-4-ona y sus sales, composiciones y aplicaciones
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
MX2007000505A (es) Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
TW200509892A (en) Novel aminobenzophenone compounds
WO2006021379A8 (de) Dihydropteridinonderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
MX2009003958A (es) Nuevos derivados de 1,4-benzotiepina-1,1-dioxido sustituidos con radicales bencilo, metodo para su preparacion, productos farmaceuticos que comprenden estos compuestos y su uso.
WO2006021378A8 (de) Dihydropteridinonderivate, verfahren zu deren herstellung und deren verwendung als arzneimittel
WO2006100081A3 (de) Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung
NO20082096L (no) Azaindol-2-karboksamidderivativer
TW200604196A (en) New quinuclidine derivatives and pharmaceutical compositions comprising them
WO2009067493A3 (en) 1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders
MX2007011698A (es) Derivados de oxindol sustituido, medicamentos que contienen dichos derivados y uso de los mismos.
CR9182A (es) Derivado de quinolina, su uso, preparacion y medicamento que lo contiene
ATE407126T1 (de) Herstellung von (s)-4-fluormethyl-dihydro-furan-2-on
CL2008002689A1 (es) Compuestos derivados de heterociclo 1,4 piperidina sustituida; compuestos intermediarios; composicion farmaceutica; proceso de preparacion; y su uso en el tratamiento del alzheimer y esquizofrenia.
TW200716564A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
JO2682B1 (en) Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof
ATE380188T1 (de) Substituierte chinolone
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
MX2009000768A (es) Lactamas macrociclicas.
ATE512968T1 (de) 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6- carboxamid und 2,3,4,5-tetrahydropyrrolo(1,2-a)- diazepin-7-carboxamid- derivate, ihre herstellung und therapeutische verwendung
ATE524463T1 (de) 4-chromenonyl-1,4-dihydropyridincarbonitrile und ihre verwendung
UA86873C2 (en) SUBSTITUTED ARYL 1,4-PYRAZlNE DERIVATIVES

Legal Events

Date Code Title Description
8364 No opposition during term of opposition